{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-109575","form_type":"8-K","ticker":"PTPI","cik":"0001815903","company_name":"Petros Pharmaceuticals, Inc.","filed_at":"2024-10-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.788218+00:00","generated_at":"2026-05-30T13:25:02.737819+00:00","sec_items":["1.01","3.03","5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Petros Pharmaceuticals amends Series A Preferred to grant voting rights at $2.25 conversion price","bullets":["Amendment grants Series A Preferred holders voting rights on as-converted basis at $2.25/share conversion price.","Certificate of Amendment filed with Delaware Secretary of State, effective October 11, 2024.","Required Holders (majority of outstanding preferred) agreed; no additional consideration paid to investors.","Amendment modifies terms from original July 2023 Securities Purchase Agreement; no other changes to transaction documents."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-109575","json":"https://secwatch.observer/filing/0001104659-24-109575.json","markdown":"https://secwatch.observer/filing/0001104659-24-109575.md","text":"https://secwatch.observer/filing/0001104659-24-109575.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1815903/000110465924109575/0001104659-24-109575-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1815903/000110465924109575/tm2426416d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T13:25:02.737819+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}